Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved

Patent No. EP2560662 (titled "Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved") was filed by Alfasigma on Apr 20, 2011. The application was issued on Jun 7, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOTTI & FERRARIMar 7, 2018FERRECCIO
GENERICS UKMar 7, 2018FRKELLY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2560662

ALFASIGMA
Application Number
EP11723652A
Filing Date
Apr 20, 2011
Status
Revoked
Mar 6, 2020
Publication Date
Jun 7, 2017